menu
The “Antibody Contract Manufacturing Market, 2020-2030” report - Roots Analysis'
The “Antibody Contract Manufacturing Market, 2020-2030” report  - Roots Analysis'
Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well.

. Presently,there are a number of companies that claim to offer end-to-end solutions,ranging from antibody development to commercial production. Further, prevalenttrends suggest that sponsor companies are likely to continue relying oncontract service providers for various aspects of antibody-based productdevelopment and manufacturing.

 

To order this 285+ page report, which features100+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

 

The USD 17 billion (by 2030) financial opportunitywithin the antibody contract manufacturing market has been analyzed across thefollowing segments:

§ Type of Antibodies

§ Monoclonal Antibodies

§ Bispecific Antibodies

§ ADCs

§ Others

 

§ Company Size

§ Small

§ Mid-sized

§ Large / Very Large

 

§ Scale of Operation

§ Preclinical / Clinical

§ Commercial

 

§ Type of expressionsystem used

§ Mammalian

§ Microbial

 

§ Key geographicalregions

§ North America

§ Europe

§ Asia and RoW

 

TheAntibody Contract Manufacturing Market, 2020-2030 reportfeatures the following companies, which we identified to be key players in thisdomain: 

§ AGC Biologics

§ Aldevron

§ AMRI

§ Boehringer IngelheimBioXcellence

§ Emergent BioSolutions

§ Eurofins CDMO

§ FUJIFILM DiosynthBiotechnologies

§ KBI Biopharma

§ Lonza

§ Nitto Avecia PharmaServices

§ Novasep

§ Pierre Fabre

§ Samsung BioLogics

§ Synthon

§ Thermo Fisher Scientific

 

Table of Contents

 

1. Preface

 

2. Executive Summary

 

3. Introduction

 

4. Market Landscape

 

5. Company Competitive Analysis

 

6. Company Profiles

 

7. Case Study: Comparison ofSmall and Large Molecules (Biologics) Drugs / Therapies

 

8. Benchmark Analysis

 

9. Partnerships

 

10. Recent Expansions

 

11. Capacity Analysis

 

12. Demand Analysis

 

13. Market Sizing andOpportunity Analysis

 

14. SWOT Analysis

 

15. Future of The Antibody CMOMarket

 

16. Interview Transcripts

 

17. Appendix 1: List of AntibodyCustom Manufacturers

 

18. Appendix 2: Tabulated Data

 

19. Appendix 3: List ofCompanies and Organizations

Topurchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

 

ContactDetails

GauravChaudhary

+1(415) 800 3415

gaurav.chaudhary@rootsanalysis.com